|
Private equity firms have invested in the health care companies at astonishing rates. While a variety of forces draw these investors in, questions arise about their role: Who is being targeted and why? What is the impact on patients? And what do these changes mean for costs and quality of care?
Join The Leonard Davis Institute of Health Economics at the University of Pennsylvania (LDI) to learn more about trends in private equity transactions in health care, while examining the impact on health equity, health outcomes, and health care delivery, and whether there should be policy responses to these investments.
Supported by the Charles C. Leighton, MD Memorial Lecture Fund.
|
|
|
|
Atul Gupta, PhD
Assistant Professor, Health Care Management, The Wharton School
|
|
|
|
|
|
Anaeze C. Offodile II, MD, MPH
Executive Director, Clinical Transformation and Assistant Professor, Department of Plastic Surgery, MD Anderson Cancer Center
|
|
|
|
|
|
Rachel M. Werner, MD, PhD (moderator)
Executive Director, Penn LDI; Robert D. Eilers Professor of Health Care Management and Economics, The Wharton School; Professor, Medicine, Perelman School of Medicine
|
|
|
|
The Leonard Davis Institute of Health Economics at the University of Pennsylvania is one of the world’s leading university institutes, guided by our mission to improve health and health care by catalyzing collaborative, multidisciplinary research that influences policy and practice.
|
|
|
|
